What is Biodesix, Inc.'s cash ratio?

Biodesix, Inc. (BDSX) reported cash ratio of 1.8× in Q1 2026.

How has Biodesix, Inc.'s cash ratio changed year-over-year?

Biodesix, Inc.'s cash ratio increased by 33.5% year-over-year, from 1.3× to 1.8×.

What is the long-term trend for Biodesix, Inc.'s cash ratio?

Over 5 years (2020 to 2025), Biodesix, Inc.'s cash ratio has grown at a -10.9% compound annual growth rate (CAGR), from 1.9× to 1.1×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Biodesix, Inc. BDSX Cash ratio

Cash ratio at other companies

NeoGenomicsNEO

1.7×+0.5×

VeracyteVCYT

4.7×+2.2×

Adaptive BiotechnologiesADPT

0.9×+0.3×

Personalis, Inc.PSNL

1.9×-0.5×

Guardant HealthGH

3.8×+0.2×

Tempus AI, Inc.TEM

1.7×+1.2×

Other financials

Income statement

See full

Revenue$25.6M+42.3%

Operating income-$6.2M+32.1%

Net income-$7.8M+29.8%

EPS (diluted)-$0.81+46.7%

Balance sheet

See full

Cash & equivalents$25.6M+45.3%

Total debt$71.6M+15.0%

Total equity$9.1M-17.4%

Total assets$94.6M+9.7%

Cash flow

See full

Operating cash flow-$10.2M-18.2%

CapEx$81.0K+9.5%

Free cash flow-$10.2M-18.1%

Valuation

See full

Market cap$233.52M+476%

Enterprise value$279.56M+204%

P/S2.4×+1.9×

Profitability

See full

Operating margin-26%-7.5pp

Net margin-33.3%-9.3pp

FCF margin-26.8%-9.6pp

Returns & leverage

See full

Return on equity-316.5%—

Debt / equity7.8×+2.2×

Current ratio2.8×+0.6×

Where this comes from

Calculated from Biodesix, Inc.’s reported figures.

cash and equivalents/total current liabilities=1.8×

Based on the most recent quarter.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biodesix, Inc.'s cash ratio?: Biodesix, Inc. (BDSX) reported cash ratio of 1.8× in Q1 2026.
How has Biodesix, Inc.'s cash ratio changed year-over-year?: Biodesix, Inc.'s cash ratio increased by 33.5% year-over-year, from 1.3× to 1.8×.
What is the long-term trend for Biodesix, Inc.'s cash ratio?: Over 5 years (2020 to 2025), Biodesix, Inc.'s cash ratio has grown at a -10.9% compound annual growth rate (CAGR), from 1.9× to 1.1×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.